BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32091426)

  • 21. Efficacy of milrinone and dobutamine in low cardiac output states: Systematic review and meta-analysis.
    Mathew R; Visintini SM; Ramirez FD; DiSanto P; Simard T; Labinaz M; Hibbert BM
    Clin Invest Med; 2019 Jun; 42(2):E26-32. PubMed ID: 31228965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.
    Wang XC; Zhu DM; Shan YX
    Am J Cardiovasc Drugs; 2015 Dec; 15(6):429-37. PubMed ID: 26123415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A
    Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
    Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rotating inotrope therapy in a pediatric population with decompensated heart failure.
    Ryerson LM; Alexander PM; Butt WW; Shann FA; Penny DJ; Shekerdemian LS
    Pediatr Crit Care Med; 2011 Jan; 12(1):57-60. PubMed ID: 20453705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
    Cuffe MS; Califf RM; Adams KF; Benza R; Bourge R; Colucci WS; Massie BM; O'Connor CM; Pina I; Quigg R; Silver MA; Gheorghiade M;
    JAMA; 2002 Mar; 287(12):1541-7. PubMed ID: 11911756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the effects of milrinone and olprinone in patients with congestive heart failure.
    Dobashi S; Watanabe I; Nakanishi R; Hisatake S; Kiuchi S; Kabuki T; Oka T; Fujii T; Ikeda T
    Heart Vessels; 2020 Jun; 35(6):776-785. PubMed ID: 31865433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine.
    Nuñez S; Maisel A
    Am Heart J; 1998 Mar; 135(3):383-8. PubMed ID: 9580093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure.
    Kobayashi S; Susa T; Tanaka T; Murakami W; Fukuta S; Okuda S; Doi M; Wada Y; Nao T; Yamada J; Okamura T; Yano M; Matsuzaki M
    Circ J; 2012; 76(7):1646-53. PubMed ID: 22481100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study.
    Felker GM; Benza RL; Chandler AB; Leimberger JD; Cuffe MS; Califf RM; Gheorghiade M; O'Connor CM;
    J Am Coll Cardiol; 2003 Mar; 41(6):997-1003. PubMed ID: 12651048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
    Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
    J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of dobutamine vs milrinone in sepsis: A big data, real-world study.
    Zhu Y; Yin H; Zhang R; Ye X; Wei J
    Int J Clin Pract; 2021 Nov; 75(11):e14689. PubMed ID: 34331721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inotropic therapy for right ventricular failure in newborn piglets: effect on contractility, hemodynamics, and interventricular interaction.
    Hyldebrandt JA; Frederiksen CA; Heiberg J; Rothmann S; Redington AN; Schmidt MR; Ravn HB
    Pediatr Crit Care Med; 2014 Sep; 15(7):e327-33. PubMed ID: 25080150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
    Biddle TL; Benotti JR; Creager MA; Faxon DP; Firth BG; Fitzpatrick PG; Konstam MA; Krebs C; Walton L; Kershner RP
    Am J Cardiol; 1987 Jun; 59(15):1345-50. PubMed ID: 3591689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
    Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
    Br J Anaesth; 2006 Dec; 97(6):799-807. PubMed ID: 17035336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.
    Siostrzonek P; Koreny M; Delle-Karth G; Haumer M; Koller-Strametz J; Heinz G
    Acta Anaesthesiol Scand; 2000 Apr; 44(4):403-9. PubMed ID: 10757572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
    Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of nesiritide versus milrinone in the treatment of acute decompensated heart failure.
    Lewis DA; Gurram NR; Abraham WT; Akers WS
    Am J Health Syst Pharm; 2003 Aug; 60 Suppl 4():S16-20. PubMed ID: 12966902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The choice of perioperative inotropic support impacts the outcome of small infants undergoing complex cardiac surgery: an observational study.
    Willems A; Havaux R; Schmartz D; Fils JF; DE Pooter F; VAN DER Linden P
    Minerva Anestesiol; 2023 Sep; 89(9):753-761. PubMed ID: 37676176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.